National Health Investors, Inc.
NHI
$71.67
$0.210.29%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | 65.78M | 63.32M | 65.76M | 62.19M | 60.72M |
Total Other Revenue | 19.97M | 19.63M | 19.45M | 19.49M | 19.30M |
Total Revenue | 85.76M | 82.94M | 85.21M | 81.68M | 80.02M |
Cost of Revenue | 2.84M | 2.79M | 3.21M | 2.74M | 2.78M |
Gross Profit | 82.91M | 80.16M | 82.00M | 78.94M | 77.25M |
SG&A Expenses | 5.83M | 5.05M | 5.04M | 5.88M | 5.07M |
Depreciation & Amortization | 18.68M | 17.77M | 17.49M | 17.51M | 17.11M |
Other Operating Expenses | 10.85M | 10.83M | 10.48M | 10.13M | 10.07M |
Total Operating Expenses | 38.20M | 36.43M | 36.22M | 36.25M | 35.02M |
Operating Income | 47.55M | 46.51M | 48.99M | 45.43M | 45.00M |
Income Before Tax | 42.79M | 28.24M | 34.95M | 30.66M | 31.72M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | 42.79M | 28.24M | 34.95M | 30.66M | 31.72M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | 455.00K | 298.00K | 304.00K | 290.00K | 327.00K |
Net Income | 43.24M | 28.54M | 35.26M | 30.95M | 32.05M |
EBIT | 47.55M | 46.51M | 48.99M | 45.43M | 45.00M |
EBITDA | 66.23M | 64.28M | 66.48M | 62.93M | 62.11M |
EPS Basic | 0.96 | 0.66 | 0.81 | 0.71 | 0.74 |
Normalized Basic EPS | 0.46 | 0.46 | 0.50 | 0.45 | 0.44 |
EPS Diluted | 0.95 | 0.65 | 0.81 | 0.71 | 0.74 |
Normalized Diluted EPS | 0.45 | 0.46 | 0.50 | 0.45 | 0.44 |
Average Basic Shares Outstanding | 45.12M | 43.48M | 43.40M | 43.39M | 43.39M |
Average Diluted Shares Outstanding | 45.44M | 43.99M | 43.56M | 43.42M | 43.39M |
Dividend Per Share | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 |
Payout Ratio | 90.79% | 137.00% | 110.85% | 126.24% | 121.92% |